ATE330633T1 - Epoxy-steroidaler aldosteronantagonist und beta- adrenergischer antagonist-kombinationstherapie zur behandlung von kongestivem herzversagen - Google Patents

Epoxy-steroidaler aldosteronantagonist und beta- adrenergischer antagonist-kombinationstherapie zur behandlung von kongestivem herzversagen

Info

Publication number
ATE330633T1
ATE330633T1 AT01957290T AT01957290T ATE330633T1 AT E330633 T1 ATE330633 T1 AT E330633T1 AT 01957290 T AT01957290 T AT 01957290T AT 01957290 T AT01957290 T AT 01957290T AT E330633 T1 ATE330633 T1 AT E330633T1
Authority
AT
Austria
Prior art keywords
beta
epoxy
antagonist
combination therapy
adrenergic
Prior art date
Application number
AT01957290T
Other languages
English (en)
Inventor
John C Alexander
Joseph R Schuh
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Application granted granted Critical
Publication of ATE330633T1 publication Critical patent/ATE330633T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AT01957290T 2000-07-27 2001-07-27 Epoxy-steroidaler aldosteronantagonist und beta- adrenergischer antagonist-kombinationstherapie zur behandlung von kongestivem herzversagen ATE330633T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22136500P 2000-07-27 2000-07-27

Publications (1)

Publication Number Publication Date
ATE330633T1 true ATE330633T1 (de) 2006-07-15

Family

ID=22827509

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01957290T ATE330633T1 (de) 2000-07-27 2001-07-27 Epoxy-steroidaler aldosteronantagonist und beta- adrenergischer antagonist-kombinationstherapie zur behandlung von kongestivem herzversagen

Country Status (11)

Country Link
US (3) US20020123485A1 (de)
EP (1) EP1303306B1 (de)
JP (1) JP2004511435A (de)
AT (1) ATE330633T1 (de)
AU (2) AU2001279050B2 (de)
CA (1) CA2415789A1 (de)
DE (1) DE60120982T2 (de)
DK (1) DK1303306T3 (de)
ES (1) ES2265437T3 (de)
PT (1) PT1303306E (de)
WO (1) WO2002009760A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003049745A1 (en) * 2001-12-12 2003-06-19 Pharmacia Corporation Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
JP2005519918A (ja) * 2002-01-30 2005-07-07 ファルマシア・コーポレーション 病因性状態を予防または治療するためのアルドステロン受容体拮抗剤およびα−アドレナリン作用変調剤の組み合わせ治療
MXPA04009033A (es) * 2002-03-18 2005-01-25 Pharmacia Corp Combinacion de un antagonista de receptor de aldosterona y acido nicotinico o un derivado de acido nicotinico.
US6967194B1 (en) * 2002-09-18 2005-11-22 Susan Matsuo Bio-identical hormones and method of use
US20040229901A1 (en) * 2003-02-24 2004-11-18 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist
US20040266743A1 (en) * 2003-05-09 2004-12-30 Pharmacia Corporation Combination of an aldosterone receptor antagonist and a renin inhibitor
JP2007528400A (ja) 2004-03-09 2007-10-11 エラン ファーマシューティカルズ，インコーポレイテッド 置換ヒドロキシエチルアミン系のアスパラギン酸プロテアーゼ阻害薬
US7803838B2 (en) 2004-06-04 2010-09-28 Forest Laboratories Holdings Limited Compositions comprising nebivolol
US7838552B2 (en) 2004-06-04 2010-11-23 Forest Laboratories Holdings Limited Compositions comprising nebivolol
DE102004035322A1 (de) * 2004-07-21 2006-02-16 Universität des Saarlandes Selektive Hemmstoffe humaner Corticoidsynthasen
CN104644627A (zh) 2004-09-14 2015-05-27 科罗拉多大学董事会 基于基因靶向使用布新洛尔的治疗方法
US9271963B2 (en) * 2005-03-03 2016-03-01 Universitat Des Saarlandes Selective inhibitors of human corticosteroid synthases
WO2007047305A1 (en) 2005-10-12 2007-04-26 Elan Pharmaceuticals, Inc. Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
DE102008022221A1 (de) 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
US8541404B2 (en) * 2009-11-09 2013-09-24 Elexopharm Gmbh Inhibitors of the human aldosterone synthase CYP11B2
PE20190446A1 (es) * 2016-06-22 2019-03-29 Univ Vanderbilt Moduladores alostericos positivos del receptor muscarinico de acetilcolina m4
US11008335B2 (en) 2016-11-07 2021-05-18 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor M4
JP7099725B2 (ja) 2016-11-07 2022-07-12 ヴァンダービルト ユニヴァーシティ ムスカリン性アセチルコリンレセプターｍ４のポジティブアロステリック調節因子
US10927126B2 (en) 2016-11-07 2021-02-23 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor M4
TW201930311A (zh) 2017-12-05 2019-08-01 泛德比爾特大學 蕈毒鹼型乙醯膽鹼受體m4之正向別構調節劑
CN111406058A (zh) 2017-12-05 2020-07-10 范德比尔特大学 毒蕈碱型乙酰胆碱受体m4的正向别构调节剂
WO2023060245A1 (en) * 2021-10-08 2023-04-13 The United States Government As Represented By The Department Of Veterans Affairs Methods for predicting drug responsiveness in heart failure subjects

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA6808345B (en) * 1967-12-22 May & Baker Ltd Benzene derivatives
US3641152A (en) * 1968-09-23 1972-02-08 Warner Lambert Pharmaceutical 3 4-dihydronaphthalenoneoxy-2-hydroxy-propylamines
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
US4340541A (en) * 1975-08-15 1982-07-20 Sandoz Ltd. 4-(2-Benzoyloxy-3-tert.-butylaminopropoxy-2-methyl indole
FR2330383A1 (fr) * 1975-11-06 1977-06-03 Synthelabo Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4346106A (en) * 1981-05-14 1982-08-24 E. R. Squibb & Sons, Inc. Method for inhibiting onset of migraine headaches with nadolol compositions
FI77669C (fi) * 1983-04-13 1989-04-10 Ciba Geigy Ag 20-spiroxaner och analoger, som innehaoller en oeppen ring e, foerfarande foer deras framstaellning samt dessa innehaollande farmaceutiska preparat.
US4752263A (en) * 1984-06-29 1988-06-21 Cuda International Corporation Custom underwater diving system
FR2634376B1 (fr) * 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
AU642066B2 (en) * 1991-01-25 1993-10-07 Nanosystems L.L.C. X-ray contrast compositions useful in medical imaging
US5123555A (en) * 1991-05-01 1992-06-23 Cap Snap Co. Container cap having external bead
US5190765A (en) * 1991-06-27 1993-03-02 Alza Corporation Therapy delayed
IT1252024B (it) * 1991-11-29 1995-05-27 Pirelli Transmissioni Ind Spa Procedimento per la fabbricazione di cinghie dentate in materiale elastomerico,e cinghia dentata ottenuta mediante tale procedimento
US5373004A (en) * 1993-11-24 1994-12-13 Wisconsin Alumni Research Foundation 26,28-methylene-1α, 25-dihydroxyvitamin D2 compounds
US5451652A (en) * 1994-04-28 1995-09-19 Arco Chemical Technology, L.P. Polymers from propoxylated allyl alcohol
US5747001A (en) * 1995-02-24 1998-05-05 Nanosystems, L.L.C. Aerosols containing beclomethazone nanoparticle dispersions
US5965034A (en) * 1995-12-04 1999-10-12 Mc Electronics Co., Ltd. High frequency plasma process wherein the plasma is executed by an inductive structure in which the phase and anti-phase portion of the capacitive currents between the inductive structure and the plasma are balanced
US6541479B1 (en) * 1997-12-02 2003-04-01 Massachusetts College Of Pharmacy Calcium channel blockers
US6047407A (en) * 1997-12-29 2000-04-11 Habel; Carolyn Louise Hat with candles depicted thereon
UA74141C2 (uk) * 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
US6429878B1 (en) * 1999-12-28 2002-08-06 Ge Medical Systems Global Technology Company, Llc Display of text on medical images
US6495235B2 (en) * 2000-03-24 2002-12-17 Matsushita Electric Industrial Co., Ltd. Optical disk, substrate of the same, and mold for forming the substrate

Also Published As

Publication number Publication date
EP1303306A2 (de) 2003-04-23
DK1303306T3 (da) 2006-10-23
CA2415789A1 (en) 2002-02-07
AU7905001A (en) 2002-02-13
JP2004511435A (ja) 2004-04-15
US20050215537A1 (en) 2005-09-29
EP1303306B1 (de) 2006-06-21
AU2001279050B2 (en) 2006-10-19
ES2265437T3 (es) 2007-02-16
US20020123485A1 (en) 2002-09-05
DE60120982T2 (de) 2007-02-08
PT1303306E (pt) 2006-11-30
DE60120982D1 (de) 2006-08-03
WO2002009760A3 (en) 2003-01-23
WO2002009760A9 (en) 2003-09-04
WO2002009760A2 (en) 2002-02-07
US20040235809A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
DE60120982D1 (de) Epoxy-steroidaler aldosteronantagonist und beta-adrenergischer antagonist-kombinationstherapie zur behandlung von kongestivem herzversagen
ATE357257T1 (de) Kombinationstherapie mit epoxy-steroidalen aldosteronantagonisten und kalziumkanalblocker zur behandlung von kongestivem herzversagen
MXPA05010507A (es) Combinacion de un antagonista del receptor de aldosterona y un agente antiobesidad.
BRPI0408362A (pt) combinação de um antagonista de receptor de aldosterona e um agente antidiabético
DK0831910T3 (da) Kombinationsterapi med epoxy-steroid aldosteronantagonist og angiotensin II-receptorantagonist til behandling af kongestivt hjertesvigt
ATE216261T1 (de) Kombinationstherapie zur behandlung des kongestiven herzversagens mit spironolacton und angiotensin ii-antagonist
LV12639B (lv) Bifenilsulfonamidi ka duali angiotenzina un endotelina receptoru antagonisti
JP2004511522A5 (de)
CY1110173T1 (el) Χρηση της (11 beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one στη θεραπεια μειζωνος καταθλιπτικης διαταραχης
DE69736833D1 (de) Steroide als neurochemische stimulatoren des nasenraumes zur linderung der prämenstrualen symptome
WO2003063846A3 (en) Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of cardiovascular conditions
TW200501937A (en) Combination of an aldosterone receptor antagonist and an anti-diabetic agent
ATE277071T1 (de) Durch 11-beta-aryl-17,17-spirothiolan substituierte steroide
MX9709976A (es) Terapia de combinacion con espironolactona y antagonista de angiotensina ii para el tratamiento de fallas cardiacas congestivas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1303306

Country of ref document: EP

REN Ceased due to non-payment of the annual fee